Founded in 2004 as Clinical Research Hamburg GmbH and acquired by Velocity Clinical Research in 2022, the experienced team at Velocity’s dedicated research site in Hamburg conducts Phase 2-4 clinical trials across a broad variety of indications. The site partners with specialists in dermatology, orthopedics, gynecology, internal medicine, and general medicine. By developing strong working relationships with local communities and having close ties with networks of cooperating practices, Velocity’s Hamburg staff provides fast, accurate patient enrolment support, even for diverse populations.
Our Hamburg team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in Hamburg, Velocity will deliver the right patients, investigators, and research staff for your next research program.
Now Enroling in Hamburg
Velocity is enroling participants for clinical trials in Hamburg for the following conditions:
- Asthma
- Chronic Lower Back Pain
- COPD
- Gout with Hyperuricemia
- Hypertension (High Blood Pressure)
- Osteoarthritis of the Knee
- Vaping Cessation